The challenges of developing ultra-sensitive diagnostic assays
31 July, 2017
Nick Collier, Ph.D. describes the technical hurdles behind designing the next generation of in vitro diagnostic systems.
Ultra-sensitive diagnostic assays are used to diagnose and detect the early onset of disease. Sagentia is at the forefront of research and development in clinical diagnostics, having completed more than 500 IVD projects for our clients ranging from low-cost home-use devices to single molecule sequencing platforms.
In the article published at the link below, we assess the technical challenges which should be considered when designing the next generation of in vitro diagnostics systems.
The full article was published by MD&DI and can be found here.
